Alpa Laboratories Financial Statements
Alpa Laboratories Annually Results
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 36.80 | (1) | 18.40 | (6.60) |
| Op profit growth | (20) | (41) | 4.08 | 99.90 |
| EBIT growth | (45) | (40) | (15) | 7,946 |
| Net profit growth | (34) | 10.70 | (63) | (590) |
| Profitability ratios (%) | ||||
| OPM | 3.90 | 6.70 | 11.20 | 12.70 |
| EBIT margin | 3.61 | 9.06 | 14.90 | 20.90 |
| Net profit margin | 2.16 | 4.44 | 3.97 | 12.80 |
| RoCE | 3.04 | 5.45 | 8.48 | 9.61 |
| RoNW | 0.47 | 0.73 | 0.67 | 1.90 |
| RoA | 0.45 | 0.67 | 0.56 | 1.47 |
| Per share ratios () | ||||
| EPS | 0.88 | 1.33 | 1.20 | 3.25 |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (0.60) | (0.20) | (0.10) | 2.86 |
| Book value per share | 47.70 | 46.40 | 45 | 44.40 |
| Valuation ratios | ||||
| P/E | 16 | 29.20 | 33.70 | 11.80 |
| P/CEPS | (23) | (226) | (323) | 13.40 |
| P/B | 0.30 | 0.84 | 0.90 | 0.86 |
| EV/EBIDTA | 3.81 | 7.52 | 4.82 | 5.66 |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (36) | (40) | (40) | (30) |
| Liquidity ratios | ||||
| Debtor days | 107 | 160 | 183 | 200 |
| Inventory days | 55.80 | 77.70 | 80.60 | 76.70 |
| Creditor days | (60) | (85) | (105) | (108) |
| Leverage ratios | ||||
| Interest coverage | (16) | (5.30) | (5.50) | (7.70) |
| Net debt / equity | (0.10) | (0.20) | (0.30) | (0.10) |
| Net debt / op. profit | (1.70) | (3.60) | (3.70) | (1.80) |
| Cost breakup () | ||||
| Material costs | (59) | (58) | (57) | (52) |
| Employee costs | (14) | (16) | (14) | (13) |
| Other costs | (23) | (19) | (18) | (22) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Revenue | 86 | 62.80 | 63.50 | 53.60 |
| yoy growth (%) | 36.80 | (1) | 18.40 | (6.60) |
| Raw materials | (51) | (36) | (36) | (28) |
| As % of sales | 59.30 | 57.70 | 57.20 | 52 |
| Employee costs | (12) | (10) | (8.70) | (7.20) |
| As % of sales | 13.80 | 16.30 | 13.70 | 13.40 |
| Other costs | (20) | (12) | (11) | (12) |
| As % of sales | 23 | 19.30 | 17.90 | 21.80 |
| Operating profit | 3.36 | 4.21 | 7.11 | 6.83 |
| OPM | 3.90 | 6.70 | 11.20 | 12.70 |
| Depreciation | (3.20) | (3.20) | (2.80) | (0.80) |
| Interest expense | (0.20) | (1.10) | (1.70) | (1.40) |
| Other income | 2.91 | 4.64 | 5.14 | 5.18 |
| Profit before tax | 2.91 | 4.62 | 7.75 | 9.74 |
| Taxes | (1.10) | (1.80) | (3.10) | (2.90) |
| Tax rate | (36) | (40) | (40) | (30) |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | 1.85 | 2.79 | 4.64 | 6.85 |
| Exceptional items | -- | -- | (2.10) | -- |
| Net profit | 1.85 | 2.79 | 2.52 | 6.85 |
| yoy growth (%) | (34) | 10.70 | (63) | (590) |
| NPM | 2.16 | 4.44 | 3.97 | 12.80 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Profit before tax | 2.91 | 4.62 | 7.75 | 9.74 |
| Depreciation | (3.20) | (3.20) | (2.80) | (0.80) |
| Tax paid | (1.10) | (1.80) | (3.10) | (2.90) |
| Working capital | (3.60) | (38) | (13) | 13.40 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | (5) | (38) | (12) | 19.50 |
| Capital expenditure | (62) | 14.10 | 5.60 | (5.60) |
| Free cash flow | (67) | (24) | (6) | 13.90 |
| Equity raised | 145 | 139 | 144 | 139 |
| Investments | 56.60 | 20.50 | 0.56 | (0.60) |
| Debt financing/disposal | (23) | (23) | (14) | 13.50 |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 112 | 113 | 125 | 166 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 21 | 21 | 21 | 21 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 79.30 | 77.50 | 76.50 | 73.70 |
| Net worth | 100 | 98.50 | 97.60 | 94.70 |
| Minority interest | ||||
| Debt | 0.41 | 1.67 | 5.98 | 10.70 |
| Deferred tax liabilities (net) | -- | -- | -- | -- |
| Total liabilities | 101 | 100 | 104 | 105 |
| Fixed assets | 7.23 | 7.90 | 10.20 | 15.40 |
| Intangible assets | ||||
| Investments | 56.60 | 48.60 | 30.60 | 12.70 |
| Deferred tax asset (net) | 0.93 | 0.17 | 0.76 | 0.66 |
| Net working capital | 29.90 | 42.60 | 40.70 | 39.90 |
| Inventories | 12.60 | 14 | 13.70 | 13 |
| Inventory Days | 53.30 | -- | 79.70 | 75 |
| Sundry debtors | 24.60 | 30 | 26 | 29.20 |
| Debtor days | 104 | -- | 151 | 168 |
| Other current assets | 13.30 | 19.60 | 19 | 17.80 |
| Sundry creditors | (14) | (13) | (13) | (14) |
| Creditor days | 58.30 | -- | 77.30 | 80.20 |
| Other current liabilities | (6.80) | (7.90) | (4.70) | (6.20) |
| Cash | 6.17 | 0.90 | 21.30 | 36.70 |
| Total assets | 101 | 100 | 104 | 105 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|---|
| Gross Sales | 97.60 | 86 | 78 | 62.90 | 63.50 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 97.60 | 86 | 78 | 62.90 | 63.50 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 4.40 | 2.91 | 5.30 | 4.64 | 5.14 |
| Total Income | 102 | 88.90 | 83.30 | 67.50 | 68.60 |
| Total Expenditure ** | 89.90 | 82.60 | 76.80 | 58.60 | 58.50 |
| PBIDT | 12.10 | 6.27 | 6.44 | 8.85 | 10.10 |
| Interest | 0.08 | 0.20 | 0.57 | 1.07 | 1.71 |
| PBDT | 12 | 6.07 | 5.87 | 7.77 | 8.42 |
| Depreciation | 1.23 | 3.16 | 3.12 | 3.15 | 2.78 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 2.40 | 1.81 | 1.15 | 1.94 | 2.86 |
| Deferred Tax | 1.14 | (0.80) | 0.59 | (0.10) | 0.26 |
| Reported Profit After Tax | 7.25 | 1.85 | 1.01 | 2.79 | 2.52 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 7.25 | 1.85 | 1.01 | 2.79 | 2.52 |
| Extra-ordinary Items | -- | -- | -- | -- | (0.50) |
| Adjusted Profit After Extra-ordinary item | 7.25 | 1.85 | 1.01 | 2.79 | 3.03 |
| EPS (Unit Curr.) | 3.45 | 0.89 | 0.45 | 1.33 | 1.20 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 21 | 21 | 21 | 21 | 21 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 12.40 | 7.29 | 8.26 | 14.10 | 16 |
| PBDTM(%) | 12.30 | 7.06 | 7.53 | 12.40 | 13.30 |
| PATM(%) | 7.43 | 2.15 | 1.30 | 4.44 | 3.97 |
QuickLinks for Alpa Laboratories Ltd.
